REPH.US
id: 334, Created by Stan Vick, Scout
How it works?
- Company agreed to settle with investors to avoid further litigation
- We prepare documents and claim payout for you
Claim deadline for this case already passed by, but we can still try and file for compensation for you
E.D. Pennsylvania
Court17 Jul 2017
Class period Start23 May 2018
Class period End08 Oct 2022
Claim deadlineRecro Pharma agreed to pay $1.4 million to settle a securities class action lawsuit accusing the Company of deceiving investors about material information.
The original complaint alleged that the Company and its Leaders misled investors through a series of public statements regarding Recro’s target opportunities that allegedly inflated Recro’s stock price, in particular, they misrepresented and/or omitted Key Opinion Leader concerns about the drug IV meloxicam.
Recro Pharma agreed to settle with investors to avoid further litigation.
Alleged Offence
Other
Suspected Party
Other
Security Type
Stocks
Trade Direction
Long
Plaintiffs
John Alberici
Attorneys
Pomerantz LLP, Kaskela Law LLC, Bronstein, Gewirtz & Grossman LLC
Judge
Hon. Michael M. Baylson
Administrator
Strategic Claims Services
Court hearing date
26 October 2022
+$1,400,000
Total Settlement Amount